Meituan Enterprise Edition released the SIMPLE model: to meet the demands of enterprise consumption compliance, cost reduction and efficiency improvement, and experience improvement. Meituan Enterprise Edition held the second enterprise consumption management conference of "SIMPLE Activating Enterprise Endogenous Force" in Shanghai. At the meeting, Renmin University Business School, Meituan Enterprise Edition, Meituan Research Institute and Ipsos jointly released the SIMPLE model, focusing on serving enterprise consumption management and digital transformation. At present, the scale of consumption expenditure of enterprises in China has reached trillion level, and "integration of supply chain, scene management and control, and service performance" will become the key to competition in the future. (Sina Technology)Ministry of Finance of Korea: Korea's financial market is still facing uncertainty.Goldman Sachs: I don't agree that gold can't reach $3,000 under a strong dollar. Goldman Sachs said that we don't agree with the view that the price of gold can't rise to $3,000 per ounce by the end of 2025 when the dollar remains strong for a long time. We predict that gold will reach $3,000 per ounce by the end of 2025, and the reduction of interest rate cuts by the Federal Reserve (rather than the strengthening of the US dollar) is the downside risk of this prediction.
Trump said that he chose Andrew Feargus, Commissioner of the US Federal Trade Commission (FTC), as the FTC chairman.Kazakhstan said that Russia's Druzhba oil pipeline was not damaged by Ukraine's overnight strike.Zhongzhou Special Materials: Shareholders have transferred and reduced their shares by more than 1%. Zhongzhou Special Materials announced that shareholders holding more than 5% have transferred their shares internally and reduced their shares by more than 1%. After the shareholder completed the internal transfer among the concerted parties, its shareholding ratio changed accordingly. At the same time, the shareholder reduced his shares through the secondary market, and the reduction ratio exceeded 1%. This share change is mainly for the adjustment of shareholding within the company's shareholders, and will not have a significant impact on the company's governance structure and daily operations.
Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.Ministry of Finance of the Republic of Korea: We will pay close attention to the financial and foreign exchange market trends and take adequate measures to curb excessive fluctuations in the foreign exchange market.Meituan Enterprise Edition released the SIMPLE model: to meet the demands of enterprise consumption compliance, cost reduction and efficiency improvement, and experience improvement. Meituan Enterprise Edition held the second enterprise consumption management conference of "SIMPLE Activating Enterprise Endogenous Force" in Shanghai. At the meeting, Renmin University Business School, Meituan Enterprise Edition, Meituan Research Institute and Ipsos jointly released the SIMPLE model, focusing on serving enterprise consumption management and digital transformation. At present, the scale of consumption expenditure of enterprises in China has reached trillion level, and "integration of supply chain, scene management and control, and service performance" will become the key to competition in the future. (Sina Technology)
Strategy guide 12-14
Strategy guide 12-14
Strategy guide